CDT.NASDAQConduit Pharmaceuticals INC
Form 4: Conduit Pharmaceuticals CFO Adam Sragovicz Disposes of Restricted Stock Units
Sentiment:
SEC Form 4 Filing
Adam Sragovicz, CFO of Conduit Pharmaceuticals, disposed of 74,545 Restricted Stock Units on May 15, 2024.
Summary
- On May 15, 2024, Adam Sragovicz, the Chief Financial Officer of Conduit Pharmaceuticals Inc. (CDT), disposed of 74,545 Restricted Stock Units (RSUs).
- The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.
Sentiment
Score: 5
Explanation: Neutral sentiment as it is a standard SEC filing reporting a transaction.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of transaction: Adam Sragovicz disposed of Restricted Stock Units. |
Keywords
Form 4, Conduit Pharmaceuticals, CDT, Adam Sragovicz, CFO, Restricted Stock Units, Disposition, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.